Global Mortality Burden of Cirrhosis and Liver Cancer Attributable to Injection Drug Use, 1990–2016

We analyzed the temporal and spatial variations in mortality burden of cirrhosis and liver cancer attributable to injection drug use (IDU) from 1990 to 2016. Mortality data of IDU-attributable cirrhosis and IDU-attributable liver cancer on the global and national scales from 1990 to 2016 were collected from the Global Burden of Disease (GBD) studies. Age-period-cohort (APC) model analysis was used to analyze the global mortality trends of target disease, and spatial autocorrelation analysis based on Geographic Information System was applied to illustrate the clusters of the most epidemic countries. Globally, from 1990 to 2015, mortality rates (age-standardized, per 100,000) of IDU-attributable cirrhosis increased continually from 1.5 to 1.9, while from 0.4 to 0.9 for IDU-attributable liver cancer. The APC model analysis indicated that the increases of mortality were mainly driven by period effects, with the mortality risk increasing by 6.82-fold for IDU-attributable cirrhosis and 3.08-fold for IDU-attributable liver cancer. The spatial analysis suggested that IDU-attributable cirrhosis mortality were geographically clustered from 1990 to 2016, and hot spots were mainly located in less well developed countries of Latin America, East and Central Europe and Central Asia. Our study provides epidemiological evidence for global interventions against advanced liver disease among injection drug users (IDUs)

Attributable risk · Cancer · Cirrhosis · Cohort · Disease burden · Environmental health · Liver cancer · Liver disease · Mortality rate · Population · Demography · Hepatitis C virus research · HIV, Drug Use, Sexual Risk · Liver Disease Diagnosis and Treatment · Medicine · Epidemiology · Internal Medicine

• Time trends in the burden of stroke and subtypes attributable to PM2.5 in China from 1990 to 2019

  Open Access•Huijing Chen, Zhihua Zhou et al.•Frontiers in Public Health•2022

  Incluir item

• Chinese burden of depressive disorders from 1990 to 2021 and prediction for 2030

  Open Access•Na Yan, Chenwei Zhang et al.•BMC Psychology•2025

  Incluir item

• Regional Differences and Dynamic Evolution of Carbon Emission Intensity of Agriculture Production in China

  Open Access•Jiaxing Pang, Hengji Li et al.•International Journal of…•2020

  Incluir item

• The Estimation of Age, Period and Cohort Effects for Vital Rates

  Theodore R Holford•Biometrics•1983

  Incluir item

• Understanding the Effects of Age, Period, and Cohort on Incidence and Mortality Rates

  Theodore R Holford•Annual Review of Public Health•1991

  Incluir item

• HIV prevention, treatment, and care services for people who inject drugs

  Open Access•Bradley M Mathers, Louisa Degenhardt et al.•The Lancet•2010

  Incluir item

• Historical trends in the production and consumption of illicit drugs in Mexico

  Open Access•Jesus Bucardo, Kimberly C Brouwer et al.•Drug and Alcohol Dependence•2005

  Incluir item

• Global epidemiology of hepatitis B and hepatitis C in people who inject drugs

  Open Access•Paul K Nelson, Bradley M Mathers et al.•The Lancet•2011

  Incluir item

• Epidemiology and natural history of HCV infection

  Open Access•Behzad Hajarizadeh, J Grebely et al.•Nature Reviews Gastroenterology &…•2013

  Incluir item

• Early adolescent patterns of alcohol, cigarettes, and marijuana polysubstance use and young adult substance use outcomes in a nationally representative sample

  Open Access•Howard B Mo, Howard Barry Moss et al.•Drug and Alcohol Dependence•2014

  Incluir item

• Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2016

  Open Access•Emmanuela Gakidou, Ashkan Afshin et al.•The Lancet•2017

  Incluir item

• The increasing global health priority of substance use in young people

  Open Access•Louisa Degenhardt, Emily Stockings et al.•The Lancet Psychiatry•2016

  Incluir item

• Estimating the burden of disease attributable to injecting drug use as a risk factor for HIV, hepatitis C, and hepatitis B

  Open Access•Louisa Degenhardt, Fiona J Charlson et al.•The Lancet Infectious Diseases•2016

  Incluir item

• Natural Disasters, Armed Conflict, and Public Health

  Jennifer Leaning, Debarati Guha‐sapir et al.•New England Journal of Medicine•2013

  Incluir item

• Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015

  Open Access•Mohammad H Forouzanfar, Ashkan Afshin et al.•The Lancet•2016

  Incluir item

• The Analysis of Spatial Association by Use of Distance Statistics

  Open Access•Arthur Getis, J K Ord•Geographical Analysis•1992

  Incluir item

• Notes on Continuous Stochastic Phenomena

  P A P Moran•Biometrika•1950

  Incluir item

• Recommendations for the management of hepatitis C virus infection among people who inject drugs

  Open Access•J Grebely, Geert Robaeys et al.•International Journal of Drug…•2015

  Incluir item

• Interventions to prevent HIV and Hepatitis C in people who inject drugs

  Open Access•Georgina J Macarthur, Eva van Velzen et al.•International Journal of Drug…•2014

  Incluir item

• Hepatitis B vaccination and injecting drug use

  Open Access•Lisa Maher•International Journal of Drug…•2008

  Incluir item

• A Potential Hidden Source of Hepatitis C Infection Among Noninjecting Drug Users

  James M McMahon, Stephanie Tortu•Journal of Psychoactive Drugs•2003

  Incluir item

• A Methodological Comparison of Age-Period-Cohort Models

  Open Access•Yang, Yang Yang et al.•Sociological Methodology•2004

  Incluir item

• Some Methodological Issues in Cohort Analysis of Archival Data

  Karen Oppenheim Mason, William M Mason et al.•American Sociological Review•1973

  Incluir item

• The Intrinsic Estimator for Age-Period-Cohort Analysis

  Yang, Yang Yang et al.•American Journal of Sociology•2008

  Incluir item